Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients.

M Clemente-Postigo, M I Queipo-Ortuño, M Murri, M Boto-Ordoñez, P Perez-Martinez, C Andres-Lacueva, F Cardona, F J Tinahones

Journal: Journal of lipid research 2012;53(5):973-978

PMID: 22394503

Abstract

The low-grade inflammation observed in obesity has been associated with a high-fat diet, though this relation is not fully understood. Bacterial endotoxin, produced by gut microbiota, may be the linking factor. However, this has not been confirmed in obese patients. To study the relationship between a high-fat diet and bacterial endotoxin, we analyzed postprandial endotoxemia in morbidly obese patients after a fat overload. The endotoxin levels were determined in serum and the chylomicron fraction at baseline and 3 h after a fat overload in 40 morbidly obese patients and their levels related with the degree of insulin resistance and postprandial hypertriglyceridemia. The morbidly obese patients with the highest postprandial hypertriglyceridemia showed a significant increase in lipopolysaccharide (LPS) levels in serum and the chylomicron fraction after the fat overload. Postprandial chylomicron LPS levels correlated positively with the difference between postprandial triglycerides and baseline triglycerides. There were no significant correlations between C-reactive protein (CRP) and LPS levels. The main variables contributing to serum LPS levels after fat overload were baseline and postprandial triglyceride levels but not glucose or insulin resistance. Additionally, superoxide dismutase activity decreased significantly after the fat overload. Postprandial LPS increase after a fat overload is related to postprandial hypertriglyceridemia but not to degree of insulin resistance in morbidly obese patients.

Address: Laboratorio de Investigación Biomédica, Hospital Universitario Virgen de la Victoria, Spain.; Laboratorio de Investigación Biomédica, Hospital Universitario Virgen de la Victoria, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain.; Department of Nutrition and Food Science, XaRTA, INSA, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain; Lipid and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.; Laboratorio de Investigación Biomédica, Hospital Universitario Virgen de la Victoria, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain. Electronic address: [email protected].; CIBER Fisiopatología de la Obesidad y Nutrición (06/03), Instituto de Salud Carlos III, Málaga, Spain; Fundación IMABIS, and Servicio de Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.